IGM Biosciences, Inc. operates as a biotechnology company which develops antibodies for the treatment of cancer. It offers IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies. The company was founded in 2010 and is headquartered in Mountain View, CA.
$22.43 +0.44 (2.00%)
As of 01/27/2023 15:59:45 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.